Corona vaccine tests shut down: ‘Subject developed spinal cord inflammation’ | Abroad

The developers of the vaccine, the British-Swedish pharmaceutical company AstraZeneca and the University of Oxford, speak only of a “potentially unexplained condition.” They first want to know whether it is due to the vaccine before continuing with their trial.

The acute inflammation of the spinal cord is called transverse myelitis. This ensures that people can no longer move properly, lose feeling and have difficulty holding up urine and faeces. Such inflammation can have several causes, including a virus infection. Patients have a reasonable chance of being cured of this.

Furthest in development

Several pharmaceutical companies are working on a possible vaccine to prevent infection with the corona virus. AstraZeneca and Oxford are currently the furthest in that development. They are in so-called phase 3. That is the last step before regulators have to decide whether a product can be marketed. The Netherlands and other European countries have already reserved millions of doses with AstraZeneca.

Nine major vaccine manufacturers from Europe and the United States, including AstraZeneca, on Tuesday emphasized that they will not lower their normal safety standards, despite the great pressure that is there to quickly develop an effective corona vaccine.

–